Dr. Tarek Hammad is a renowned expert in drug safety, benefit-risk assessment, and pharmacoepidemiology, with extensive experience across regulatory, industry, and academic settings. He currently serves as Vice President and Global Head of Medical Safety for Marketed Products, Plasma-Derived Therapies, and Medical Device Safety at Takeda Pharmaceuticals. Dr. Hammad’s distinguished career spans leadership roles at major pharmaceutical companies including Sanofi and Merck, as well as a 13-year tenure at the U.S. Food and Drug Administration (FDA), where he contributed to both pre-marketing and post-marketing safety evaluations. He has received numerous prestigious awards recognizing his impact on the field, including the FDA Distinguished Service Award and the Frances Kelsey Excellence in Drug Safety Award. A sought-after speaker and active contributor to global pharmacovigilance and regulatory science initiatives, Dr. Hammad currently serves on the Advisory Board of the International Society of Pharmacovigilance (ISoP) and was the Chair of the Industry Council of the International Society for Pharmacoepidemiology (ISPE). He has also held several academic appointments in major universities and continues to advance the field through leadership, mentorship, and scientific collaboration. He has authored more than 90 peer-reviewed publications, book chapters, and letters to the editor, offering influential insights that have shaped the science and practice of pharmacovigilance and pharmacoepidemiology. Learn more about his background and experience at www.DrTarekHammad.com.